170 related articles for article (PubMed ID: 23008732)
1. The impact of osteopontin gene variations on multiple sclerosis development and progression.
Comi C; Cappellano G; Chiocchetti A; Orilieri E; Buttini S; Ghezzi L; Galimberti D; Guerini F; Barizzone N; Perla F; Leone M; D'Alfonso S; Caputo D; Scarpini E; Cantello R; Dianzani U
Clin Dev Immunol; 2012; 2012():212893. PubMed ID: 23008732
[TBL] [Abstract][Full Text] [Related]
2. The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population.
Chiocchetti A; Orilieri E; Cappellano G; Barizzone N; D' Alfonso S; D' Annunzio G; Lorini R; Ravazzolo R; Cadario F; Martinetti M; Calcaterra V; Cerutti F; Bruno G; Larizza D; Dianzani U
Int J Immunopathol Pharmacol; 2010; 23(1):263-9. PubMed ID: 20378012
[TBL] [Abstract][Full Text] [Related]
3. Association of osteopontin regulatory polymorphisms with systemic sclerosis.
Barizzone N; Marchini M; Cappiello F; Chiocchetti A; Orilieri E; Ferrante D; Corrado L; Mellone S; Scorza R; Dianzani U; D'Alfonso S
Hum Immunol; 2011 Oct; 72(10):930-4. PubMed ID: 21763380
[TBL] [Abstract][Full Text] [Related]
4. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
[TBL] [Abstract][Full Text] [Related]
5. The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population.
Mas A; Martínez A; de las Heras V; Bartolomé M; de la Concha EG; Arroyo R; Urcelay E
Mult Scler; 2007 Mar; 13(2):250-2. PubMed ID: 17439891
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.
Biernacka-Lukanty J; Michalowska-Wender G; Michalak S; Raczak B; Kozubski W; Urbanski D; Wender M
Folia Neuropathol; 2015; 53(4):343-6. PubMed ID: 26785368
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression.
Chiocchetti A; Comi C; Indelicato M; Castelli L; Mesturini R; Bensi T; Mazzarino MC; Giordano M; D'Alfonso S; Momigliano-Richiardi P; Liguori M; Zorzon M; Amoroso A; Trojano M; Monaco F; Leone M; Magnani C; Dianzani U
J Neuroimmunol; 2005 Jun; 163(1-2):172-8. PubMed ID: 15885319
[TBL] [Abstract][Full Text] [Related]
8. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.
D'Alfonso S; Barizzone N; Giordano M; Chiocchetti A; Magnani C; Castelli L; Indelicato M; Giacopelli F; Marchini M; Scorza R; Danieli MG; Cappelli M; Migliaresi S; Bigliardo B; Sabbadini MG; Baldissera E; Galeazzi M; Sebastiani GD; Minisola G; Ravazzolo R; Dianzani U; Momigliano-Richiardi P
Arthritis Rheum; 2005 Feb; 52(2):539-47. PubMed ID: 15692970
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin polymorphisms and disease course in multiple sclerosis.
Caillier S; Barcellos LF; Baranzini SE; Swerdlin A; Lincoln RR; Steinman L; Martin E; Haines JL; Pericak-Vance M; Hauser SL; Oksenberg JR;
Genes Immun; 2003 Jun; 4(4):312-5. PubMed ID: 12761568
[TBL] [Abstract][Full Text] [Related]
10. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
J Neuroimmunol; 2003 Mar; 136(1-2):125-9. PubMed ID: 12620651
[TBL] [Abstract][Full Text] [Related]
12. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
Melanitou E
Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
[TBL] [Abstract][Full Text] [Related]
13. Two frequent polymorphisms of angiotensinogen and their association with multiple sclerosis progression rate.
Hladikova M; Vašků A; Stourač P; Benešová Y; Bednařík J
J Neurol Sci; 2011 Apr; 303(1-2):31-4. PubMed ID: 21320707
[TBL] [Abstract][Full Text] [Related]
14. Genetic association of MiR-146a with multiple sclerosis susceptibility in the Chinese population.
Li Y; Du C; Wang W; Ma G; Cui L; Zhou H; Tao H; Yao L; Zhao B; Li K
Cell Physiol Biochem; 2015; 35(1):281-91. PubMed ID: 25591770
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.
Shawkatová I; Javor J; Párnická Z; Bucová M; Čopíková-Cudráková D; Michalík J; Gmitterová K; Čierny D; Buc M; Ďurmanová V
Folia Microbiol (Praha); 2017 Jul; 62(4):287-293. PubMed ID: 28130760
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin gene and clinical severity of multiple sclerosis.
Hensiek AE; Roxburgh R; Meranian M; Seaman S; Yeo T; Compston DA; Sawcer SJ
J Neurol; 2003 Aug; 250(8):943-7. PubMed ID: 12928913
[TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.
Chen Y; Liu H; Wu W; Li Y; Li J
J Exp Clin Cancer Res; 2013 Jul; 32(1):45. PubMed ID: 23883434
[TBL] [Abstract][Full Text] [Related]
19. Plasma osteopontin levels in multiple sclerosis.
Comabella M; Pericot I; Goertsches R; Nos C; Castillo M; Blas Navarro J; Río J; Montalban X
J Neuroimmunol; 2005 Jan; 158(1-2):231-9. PubMed ID: 15589058
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
